SUMMARY
While the authors have demonstrated SUMOylation`s protective role against diabetic neuropathy in type 1 diabetes, its relevance in type 2 diabetes, a prevalent disorder, remains unexplored. The impact of SUMOylation on oxidative stress modulation in neuronal tissue remains poorly understood, and nothing is known as yet about the sequence of pathophysiological events involving SUMOylation in peripheral nerves in type 2 diabetes. This increased MDH2 activity reduced ROS production, potentially serving as a protective mechanism against inflated ROS levels resulting from a dysfunctional respiratory_chain in SUMO-deficient mice. This study fills this gap by revealing that SUMOylation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.